TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14736597

Group type: EXPERIMENTAL
Intervention: Misoprostol at home
Number of subjects: 120

Group type: COMPARATOR
Intervention: Misoprostol at hospital
Number of subjects: 120
Study: 11699470

Group type: EXPERIMENTAL
Intervention: Subepithelial connective tissue graft (SCTG)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Guided tissue regeneration-based procedure (GTRC)
Number of subjects: 16
Study: 9322619

Group type: EXPERIMENTAL
Intervention: Cervical Papanicolaou smear
Number of subjects: 210

Group type: COMPARATOR
Intervention: Gram stain of vaginal secretions
Number of subjects: 210
Study: 7933819

Group type: EXPERIMENTAL
Intervention: Pulse oral calcitriol (2 micrograms thrice weekly, increased to 4 micrograms as tolerated)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intravenous calcitriol (2 micrograms thrice weekly, increased to 4 micrograms as tolerated)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Both pulse oral and intravenous calcitriol
Number of subjects: 19
Study: 2952091

Group type: EXPERIMENTAL
Intervention: Regular cigarette (nicotine content: 1.1 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Light cigarette (nicotine content: 0.6 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Comparison of regular vs light cigarette
Number of subjects: 15
Study: 29807477

Group type: EXPERIMENTAL
Intervention: belimumab 200 mg SC
Number of subjects: 662

Group type: COMPARATOR
Intervention: placebo to belimumab
Number of subjects: 662
Study: 27871284

Group type: EXPERIMENTAL
Intervention: Early mobilisation (n=54, active group)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Continued plaster cast fixation for another 3 weeks (n=55, control group)
Number of subjects: 109
Study: 24449708

Group type: EXPERIMENTAL
Intervention: Melodic Intonation Therapy (MIT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control intervention (waiting-list control)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Delayed MIT (received by control group after initial intervention)
Number of subjects: 27
Study: 16402746

Group type: EXPERIMENTAL
Intervention: Implicit task (tune stem completion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit task (cued recall)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surface feature variation (same timbre or different timbre)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Encoding task (semantic or nonsemantic)
Number of subjects: 0
Study: 12359039

Group type: EXPERIMENTAL
Intervention: Lazabemide 100 mg/day
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Lazabemide 200 mg/day
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study: 10427455

Group type: EXPERIMENTAL
Intervention: Intercostal blocks (ICB) with 5 ml 0.5% bupivacaine at the end of surgery and 6 h later
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Interpleural analgesia (IPA) with 20 ml 0.25% bupivacaine applied every 4 h using a catheter
Number of subjects: 36

Group type: COMPARATOR
Intervention: IV-opioid-PCA with piritamide (control group)
Number of subjects: 36
Study: 8789361

Group type: EXPERIMENTAL
Intervention: Speciality Care Workers (SCW)
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Primary Care Workers (PCW)
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Overall Satisfaction
Number of subjects: 947
Study: 2372459

Group type: EXPERIMENTAL
Intervention: Bolus enhanced scanning
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Delayed scanning
Number of subjects: 53

Group type: COMPARATOR
Intervention: Non-enhanced scanning
Number of subjects: 53
Study: 6101631

Group type: EXPERIMENTAL
Intervention: 7 units/kg of factor VIII
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 14 units/kg of factor VIII
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 28 units/kg of factor VIII
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 29852877

Group type: EXPERIMENTAL
Intervention: Scaling and Root Planing (SRP) followed by subgingival application of curcumin gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Scaling and Root Planing (SRP) alone
Number of subjects: 30
Study: 28255797

Group type: EXPERIMENTAL
Intervention: Acetate-buffered balanced crystalloid
Number of subjects: 150

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 150
Study: 24999785

Group type: EXPERIMENTAL
Intervention: Routine Fe (n 2184; 60 mg ferrous sulfate plus 400 μg folic acid daily throughout pregnancy)
Number of subjects: 4326

Group type: COMPARATOR
Intervention: Selective Fe (n 2142; screening and treatment for anaemia and daily intake of 1 mg folic acid)
Number of subjects: 4326
Study: 22933442

Group type: EXPERIMENTAL
Intervention: Standard model representing the current MetS definition
Number of subjects: 1928

Group type: EXPERIMENTAL
Intervention: Standard model excluding blood pressure
Number of subjects: 1928

Group type: EXPERIMENTAL
Intervention: Standard model extended with hsCRP
Number of subjects: 1928

Group type: COMPARATOR
Intervention: Standard model
Number of subjects: 1928
Study: 21564444

Group type: EXPERIMENTAL
Intervention: botulinum toxin-A (100 U Botox)
Number of subjects: 23

Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 23
Study: 18473021

Group type: EXPERIMENTAL
Intervention: Oral‐B Exceed
Number of subjects: 48

Group type: COMPARATOR
Intervention: Asian Colgate 360 masculine
Number of subjects: 48
Study: 16046439

Group type: COMPARATOR
Intervention: North America
Number of subjects: 1484

Group type: COMPARATOR
Intervention: North West Europe
Number of subjects: 1484

Group type: COMPARATOR
Intervention: Scandinavia
Number of subjects: 1484
Study: 15368824

Group type: EXPERIMENTAL
Intervention: Falls prevention service intervention (falls risk assessment and evidence-based prescription to GP)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 140
Study: 10855462

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 18
Study: 9084819

Group type: EXPERIMENTAL
Intervention: E.P.D. (Enzyme Potentiated Desensibilization)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 8256898

Group type: EXPERIMENTAL
Intervention: 750 mg ciprofloxacin daily for 7 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: 300 ng isoniazid daily for 7 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (C), isoniazid (H), rifampin (R) - regimen HRC
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rifampin (R), isoniazid (H), pyrazinamide (Z), ethambutol (E) - regimen HRZE
Number of subjects: 30
Study: 2869208

Group type: EXPERIMENTAL
Intervention: Electrocoagulation (small bipolar probe)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Not treated with electrocoagulation (control group)
Number of subjects: 204
Study: 27585399

Group type: EXPERIMENTAL
Intervention: Therapeutic soft contact lens (TSCL)
Number of subjects: 15

Group type: COMPARATOR
Intervention: No therapeutic soft contact lens (Control)
Number of subjects: 15
Study: 27815186

Group type: EXPERIMENTAL
Intervention: Strabismus surgery in contact lens group (CL)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Strabismus surgery in intraocular lens group (IOL)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Postoperative distance alignment after strabismus surgery
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Visual acuity with strabismus surgery
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Age at cataract surgery and strabismus surgery frequency
Number of subjects: 114
Study: 25516481

Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham Moxibustion (Control)
Number of subjects: 80
Study: 21095634

Group type: EXPERIMENTAL
Intervention: Calming music and standard care
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 68
Study: 20338978

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural group intervention with pedometer, 5 sessions over 12 weeks, booster session after 22 weeks
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural group intervention with pedometer
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 41
Study: 19001206

Group type: EXPERIMENTAL
Intervention: Calcium supplementation 1200 mg/d
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Calcium supplementation 600 mg/d
Number of subjects: 323

Group type: COMPARATOR
Intervention: Calcium supplementation
Number of subjects: 323
Study: 16308009

Group type: EXPERIMENTAL
Intervention: Off‐pump coronary artery bypass grafting plus autologous stem cell transplantation (CD34+)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Off‐pump coronary artery bypass grafting
Number of subjects: 20
Study: 12869120

Group type: EXPERIMENTAL
Intervention: PCR-based genotyping for blood group antigens (Rh, Kell, Duffy, Kidd)
Number of subjects: 100
Study: 10553845

Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both anesthetics
Number of subjects: 40
Study: 8875693

Group type: EXPERIMENTAL
Intervention: diatrizoate
Number of subjects: 34

Group type: COMPARATOR
Intervention: iopromide
Number of subjects: 34
Study: 1650526

Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy (HFX) at 69.6 Gy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combined Stage II and III HFX 69.6 Gy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard once-a-day irradiation (Control)
Number of subjects: 120
Study: 6922455

Group type: EXPERIMENTAL
Intervention: Behavioral instructions (behavioral control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sensory information (cognitive control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both behavioral instructions and sensory information
Number of subjects: 40

Group type: COMPARATOR
Intervention: General information
Number of subjects: 40
Study: 31308262

Group type: EXPERIMENTAL
Intervention: ropivacaine with clonidine 75 µg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: ropivacaine with dexamethasone 8 mg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: ropivacaine with buprenorphine 300 µg
Number of subjects: 160

Group type: COMPARATOR
Intervention: ropivacaine alone (control)
Number of subjects: 160
Study: 29032393

Group type: EXPERIMENTAL
Intervention: RSH‐VHL (repeated-sprint exercise with voluntary hypoventilation)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: RSH‐VHL
Number of subjects: 9

Group type: COMPARATOR
Intervention: RSN (repeated-sprint exercise with normal breathing)
Number of subjects: 9
Study: 26720443

Group type: EXPERIMENTAL
Intervention: ONO-9054 30.0 μg/mL
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: ONO-9054 (0.3, 1.0, 3.0, 10.0, 20.0, or 30.0 μg/mL)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 25453117

Group type: EXPERIMENTAL
Intervention: Repositioning suture of the erector spinae muscle
Number of subjects: 393

Group type: COMPARATOR
Intervention: Conventional suture of the erector spinae muscle
Number of subjects: 393
Study: 22957320

Group type: EXPERIMENTAL
Intervention: Ultrasonography (US)
Number of subjects: 104

Group type: COMPARATOR
Intervention: No Ultrasonography (Control)
Number of subjects: 104
Study: 19740585

Group type: EXPERIMENTAL
Intervention: Classic laryngeal mask airway (LMA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Laerdal Pocket Facemask (LPFM)
Number of subjects: 100
Study: 17694727

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo-CPAP
Number of subjects: 46
Study: 15957626

Group type: EXPERIMENTAL
Intervention: Fentanyl-propofol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fentanyl-midazolam
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 11791958

Group type: EXPERIMENTAL
Intervention: Artemisinin (500 mg for adults, 10 mg/kg for children) for 5 days followed by 2 days of placebo (A5)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Artemisinin (500 mg for adults, 10 mg/kg for children) for 7 days (A7)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Artemisinin (A5)
Number of subjects: 227
Study: 9888619

Group type: EXPERIMENTAL
Intervention: Metergoline (serotonin antagonist)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Metergoline
Number of subjects: 24
Study: 7711686

Group type: EXPERIMENTAL
Intervention: Pen-based electronic questionnaires
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional paper questionnaires
Number of subjects: 46
Study: 2547216

Group type: EXPERIMENTAL
Intervention: Mopidamol (2 x mg i.v. daily perioperatively, 3 x 500 mg orally postoperatively)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Mopidamol
Number of subjects: 270

Group type: COMPARATOR
Intervention: Mopidamol and Placebo
Number of subjects: 270
Study: 1101386

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 30153268

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 801

Group type: COMPARATOR
Intervention: No beta-blocker
Number of subjects: 801
Study: 27549212

Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 150

Group type: COMPARATOR
Intervention: LMA Supreme
Number of subjects: 150

Group type: COMPARATOR
Intervention: LMA ProSeal
Number of subjects: 150
Study: 23879735

Group type: EXPERIMENTAL
Intervention: Participants with high implicit power motive who exerted power over another person in Study 1
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Participants with high implicit achievement motive who mastered a frustrating sensorimotor task in Study 2
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control conditions in both studies
Number of subjects: 141
Study: 22744746

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention (patient education, therapeutic monitoring, communication with primary care providers)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Usual care (regular follow-up with primary care providers)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention
Number of subjects: 281
Study: 19629055

Group type: EXPERIMENTAL
Intervention: Beverage meal (25% of estimated energy need)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Solid meal (25% of estimated energy need)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Beverage meal (12.5% of estimated energy need)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Solid meal (12.5% of estimated energy need)
Number of subjects: 43
Study: 18337267

Group type: EXPERIMENTAL
Intervention: Simultaneous BIV pacing (BIV 0)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Optimized BIV pacing (with individually optimized VV interval)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Single-chamber pacing (LV or RV)
Number of subjects: 69
Study: 15864634

Group type: EXPERIMENTAL
Intervention: Inspiratory impedance threshold device (ITD) set to open at 0.7 kPa (7-cm H2O)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 18
Study: 11306850

Group type: EXPERIMENTAL
Intervention: Ketoconazole 2% shampoo
Number of subjects: 66

Group type: COMPARATOR
Intervention: Ketoconazole 1% shampoo
Number of subjects: 66
Study: 9312365

Group type: EXPERIMENTAL
Intervention: Homozygous factor V Leiden mutation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Heterozygous factor V Leiden mutation
Number of subjects: 22
Study: 8047747

Group type: EXPERIMENTAL
Intervention: Surrogate endpoints
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auxiliary endpoints
Number of subjects: 0
Study: 3148458

Group type: EXPERIMENTAL
Intervention: Vamin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Paedmin
Number of subjects: 32
Study: 2102668

Group type: EXPERIMENTAL
Intervention: Once-daily regimen
Number of subjects: 105

Group type: COMPARATOR
Intervention: Three-time daily regimen
Number of subjects: 105
Study: 30845819

Group type: EXPERIMENTAL
Intervention: Executive training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Perceptual training
Number of subjects: 0
Study: 27699880

Group type: COMPARATOR
Intervention: UVB nb (311 nm) phototherapy alone
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Combination of UVB nb and UVA (320‐400 nm) phototherapy
Number of subjects: 53
Study: 25902810

Group type: EXPERIMENTAL
Intervention: Pitolisant (BF2.649)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 23283505

Group type: EXPERIMENTAL
Intervention: Maltodextrins with glutamine (group 1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Protein powder (group 2)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Maltodextrins alone (control)
Number of subjects: 24
Study: 21332272

Group type: EXPERIMENTAL
Intervention: Polymyxin B sulfate, neomycin sulfate and gramicidin (PS) ear drops, thrice daily for 10 ± 2 days
Number of subjects: 244

Group type: COMPARATOR
Intervention: Glycerol ear drops, thrice daily for 10 ± 2 days
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Polymyxin B sulfate, neomycin sulfate and gramicidin (PS) ear drops
Number of subjects: 244
Study: 18676131

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 0

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 0
Study: 17286197

Group type: EXPERIMENTAL
Intervention: Internet administered CHQ-CF questionnaire
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Paper administered CHQ-CF questionnaire
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: Both internet and paper administration
Number of subjects: 1071
Study: 14749753

Group type: EXPERIMENTAL
Intervention: Fruit juices (1 l daily for 16 weeks)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Fruit-vegetable-concentrate (30 ml daily for 16 weeks)
Number of subjects: 41
Study: 11843990

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 9794841

Group type: EXPERIMENTAL
Intervention: Daclizumab (humanized monoclonal antibodies against the IL-2 receptor) added to standard cyclosporin-based immunosuppression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard cyclosporin-based immunosuppression
Number of subjects: 0
Study: 7529038

Group type: EXPERIMENTAL
Intervention: Aprotinin (high-dose regimen)
Number of subjects: 69

Group type: COMPARATOR
Intervention: No aprotinin (control group)
Number of subjects: 69
Study: 2908433

Group type: EXPERIMENTAL
Intervention: Epanolol (100 mg twice daily for 4 weeks)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Atenolol (100 mg once daily)
Number of subjects: 6
Study: 30790639

Group type: EXPERIMENTAL
Intervention: Variant CSL2 (Lys204Arg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Variant CSL3 (Lys203Arg/Lys204Arg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Wild-type HheC
Number of subjects: 48
Study: 27669373

Group type: EXPERIMENTAL
Intervention: 3% sodium bicarbonate saline solution for oral care
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 104
Study: 26334338

Group type: EXPERIMENTAL
Intervention: Simulation learning experience taught by senior-level students
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simulation learning experience taught by nursing faculty
Number of subjects: 60
Study: 23563246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Cognitive performance (ADAS-cog/MCI test)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Delayed recall test (New York University Paragraph Recall Test)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Medial temporal lobe atrophy (MTA) on MRI
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: APOE ε4 allele presence
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Vascular risk factors, WMH, and lacunes on MRI
Number of subjects: 426
Study: 20598442

Group type: EXPERIMENTAL
Intervention: Duloxetine hydrochloride 60-120mg/day
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study: 19357804

Group type: COMPARATOR
Intervention: Anticoagulation alone for patients without elevated cTnT
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Thrombolysis for patients with elevated cTnT
Number of subjects: 192
Study: 16464390

Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (5% glucose)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Dopamine vs Dobutamine
Number of subjects: 29
Study: 15181850

Group type: EXPERIMENTAL
Intervention: IL-2 + 5-Fu
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-Fu
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-2
Number of subjects: 0
Study: 11866422

Group type: EXPERIMENTAL
Intervention: Small volume resuscitation fluids (SVR) - a combination of hypertonic crystalloid with a colloid; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypertonic saline solution (HSD); specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Meta-analysis and sub-group analysis; specific intervention not applicable.
Number of subjects: 0
Study: 9236961

Group type: EXPERIMENTAL
Intervention: Individualized assessment and counseling with a written personal health plan
Number of subjects: 237

Group type: COMPARATOR
Intervention: Standardized assessment without additional counseling or health plan
Number of subjects: 237
Study: 7678715

Group type: EXPERIMENTAL
Intervention: Intracavitary mitoxantrone
Number of subjects: 29

Group type: COMPARATOR
Intervention: Intracavitary bleomycin
Number of subjects: 29
Study: 3314372

Group type: EXPERIMENTAL
Intervention: Chronic cerebellar stimulation (CCS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (switch 'off')
Number of subjects: 20
Study: 30297322

Group type: EXPERIMENTAL
Intervention: Single-dose metronidazole (2 g)
Number of subjects: 623

Group type: COMPARATOR
Intervention: 7-day-dose metronidazole (500 mg twice daily for 7 days)
Number of subjects: 623